Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.50 |
| ▸ | NOS1 | P29475 | 2/20 | 0.40 |
| ▸ | NOS3 | P29474 | 1/20 | 0.40 |
| ▸ | NOS2 | P35228 | 1/20 | 0.40 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.39 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.39 |
| ▸ | ANPEP | P15144 | 5/20 | 0.38 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.38 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | CTSL | P07711 | 1/20 | 0.37 |
| ▸ | CTSB | P07858 | 1/20 | 0.37 |
| ▸ | CTSS | P25774 | 1/20 | 0.37 |
| ▸ | CTSK | P43235 | 1/20 | 0.37 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2541315 | 1.00 | SLC7A5 (0.50) | SLC7A5NOS1NOS3NOS2SLC1A3 | |
| SCHEMBL66233 | 1.00 | SLC7A5 (0.50) | SLC7A5NOS1NOS3NOS2SLC1A3 | |
| Hydrochloric Acid SCHEMBL953366 | 0.98 | SLC7A5 (0.48) | SLC7A5NOS1NOS3NOS2SLC1A3 | |
| Hydrochloric Acid SCHEMBL8319401 | 0.98 | SLC7A5 (0.48) | SLC7A5NOS1NOS3NOS2SLC1A3 | |
| Hydrochloric Acid SCHEMBL953367 | 0.98 | SLC7A5 (0.48) | SLC7A5NOS1NOS3NOS2SLC1A3 | |
| Hydrochloric Acid SCHEMBL3937498 | 0.98 | SLC7A5 (0.48) | SLC7A5NOS1NOS3NOS2SLC1A3 | |
| Water SCHEMBL27480998 | 0.98 | SLC7A5 (0.48) | SLC7A5NOS1NOS3NOS2SLC1A3 | |
| Hydrochloric Acid SCHEMBL14152512 | 0.96 | SLC7A5 (0.47) | SLC7A5NOS1NOS3NOS2SLC1A3 | |
| Acetic Acid SCHEMBL28201953 | 0.93 | SLC7A5 (0.48) | SLC7A5NOS1NOS3NOS2SLC1A3 | |
| SCHEMBL6755388 | 0.91 | SLC7A5 (0.42) | SLC7A5NOS1NOS3NOS2SLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 701 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122010771-A | 6-Diazonium-5-oxo-norleucine derivative, preparation method and application | 西北工业大学深圳研究院 | 2026-05-12 | — | — | CN | claimed |
| CN-119246730-A | Method for detecting tert-butylamine residue in S-acetamidomethyl-L-cysteine-L-leucine tert-butyl ester | 上海吉奉生物科技有限公司 | 2025-01-03 | — | — | CN | claimed |
| CN-117903078-A | Amide derivative containing 3, 4-dichloro isothiazole, preparation method and application thereof | 南开大学 | 2024-04-19 | — | — | CN | claimed |
| CN-113646324-B | Linear solution phase pathway for WNT hexapeptide | 温特研究公司 | 2024-03-29 | — | — | CN | claimed |
| CN-113024637-B | Method for preparing carfilzomib by taking water-soluble alkynylamide as condensing agent | 江西师范大学 | 2023-05-16 | — | — | CN | claimed |
| CN-110269858-B | Twin medicine for treating ischemic stroke and preparation method thereof | 贵州医科大学 | 2021-07-09 | — | — | CN | claimed |
| CN-113024637-A | Method for preparing carfilzomib by using water-soluble alkynylamide as condensing agent | 江西师范大学 | 2021-06-25 | — | — | CN | claimed |
| CN-108578399-B | Application of amino acid ester compound in preparation of anti-CVB 3 virus medicine | 湖北工业大学 | 2020-01-07 | — | — | CN | claimed |
| CN-110218754-A | A kind of preparation method of anti-oxidation peptide | 海盐县凌特生物科技有限公司 | 2019-09-10 | — | — | CN | claimed |
| CN-109248187-A | A kind of Sweet Potato Leaf anti-oxidation active substance | 金华市飞凌生物科技有限公司 | 2019-01-22 | — | — | CN | claimed |
| CN-104447394-B | Novel synthesis process of ubenimex | 成都傲飞生物化学品有限责任公司 | 2017-01-18 | — | — | CN | claimed |
| CN-105646273-A | Method for synthesizing Ubenimex | 江苏吴中苏药医药开发有限责任公司 | 2016-06-08 | — | — | CN | claimed |
| CN-101437799-B | P38map kinase inhibitors | CHROMA THERAPEUTICS LTD | 2012-12-26 | — | — | CN | claimed |
| CN-101528677-A | HDAC inhibitors | CHROMA THERAPEUTICS LTD (GB) | 2009-09-09 | — | — | CN | claimed |
| CN-101437799-A | P38MAP kinase inhibitors | CHROMA THERAPEUTICS LTD (GB) | 2009-05-20 | — | — | CN | claimed |
| EP-0397652-B1 | WATER INSOLUBLE DERIVATIVES OF HYALURONIC ACID | GENZYME CORP (US) | 1996-06-05 | — | — | EP | claimed |
| EP-0397652-A4 | WATER INSOLUBLE DERIVATIVES OF HYALURONIC ACID | — | 1991-04-03 | — | — | EP | claimed |
| EP-0397652-A1 | WATER INSOLUBLE DERIVATIVES OF HYALURONIC ACID. | GENZYME CORP (US) | 1990-11-22 | — | — | EP | claimed |
| US-4937270-A | Water insoluble derivatives of hyaluronic acid | GENZYME CORPORATION (US) | 1990-06-26 | — | — | US | claimed |
| WO-1989002445-A1 | WATER INSOLUBLE DERIVATIVES OF HYALURONIC ACID | GENZYME CORPORATION (US) | 1989-03-23 | — | — | WO | claimed |